Previous 10 | Next 10 |
2024-01-27 04:45:00 ET Summary Tourlite Capital Management, LP is an asset management firm focused on long/short equity investing in public companies. Tourlite Fund, LP Founder Class returned 1.1% for the Fourth Quarter of 2023 and 8.8% for the full year. The fund has returned...
2024-01-23 16:06:07 ET More on Esperion Therapeutics Navigating Esperion Therapeutics' Surprise Secondary Offering: Some Investment Considerations Esperion Is Sitting On A Potential Blockbuster Drug Esperion Therapeutics stock slides on pricing stock offering to rais...
ANN ARBOR, Mich., Jan. 23, 2024 (GLOBE NEWSWIRE) -- Esperion Therapeutics, Inc. (“Esperion”, “we”, “us” or “our”) (Nasdaq: ESPR) announced today the closing of its previously announced underwritten public offering of 65,205,000 shares of its...
2024-01-22 17:13:06 ET Summary Esperion Therapeutics' stock gapped down after news of a stock offering but fortunately never reached the $1.50 offering price. The presentation at the JP Morgan Healthcare Conference provided little new information and failed to boost the stock. ...
2024-01-19 09:25:01 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Macy’s (NYSE: M ) layoffs are a hot topic on Friday after the retailer announced plans to cut a large number of jobs and close some stores. According to recent reports, M...
2024-01-19 09:07:26 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Wayfair (NYSE: W ) layoffs are a hot topic on Friday as the e-commerce company announces major cuts to its workforce to streamline operations. That has the company cutting 1,6...
2024-01-19 08:50:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Esperion Therapeutics (NASDAQ: ESPR ) stock is falling on Friday after the pharmaceutical company announced details for a public offering of its shares. This public offering has...
2024-01-19 08:38:04 ET More on pr-market losers & stocks. MorphoSys: Positive Pelabresib Data Finally Unlocking Upside MorphoSys: A Buying Opportunity Following Mixed Phase 3 Results In Myelofibrosis MorphoSys: Buying Constellation Was A Desperate Measure ...
2024-01-19 07:59:00 ET Summary Congress passes stopgap spending bill to avert government shutdown and buy more time for funding negotiations. Prices of diabetes drugs Mounjaro and Ozempic see increases, along with hundreds of other drugs. Nasdaq 100 reaches all-time high, driv...
2024-01-19 05:00:03 ET Related stock stories: Amazon's Reality Check All Details About Amazon's Valuation After The Huge Run Super Micro: Deteriorating Growth And Margins Means It's Time To Trim (Downgrade) For further details see: Biggest stock movers to...
News, Short Squeeze, Breakout and More Instantly...
Esperion Therapeutics Inc. Company Name:
ESPR Stock Symbol:
NASDAQ Market:
Esperion Therapeutics Inc. Website:
– OMERS Life Sciences to Purchase Esperion’s European Royalty on Bempedoic Acid Products for $304.7 Million with European Royalties Reverting to Esperion Once OMERS Receives 1.7 Times its Investment – – Esperion Retains Rights to Receive all Poten...